Type not reported
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
Enrollment reporting
Analytics
Phase 1/2
1(33.3%)
Phase 2
1(33.3%)
Phase 3
1(33.3%)
3Total
Phase 1/2(1)
Phase 2(1)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT03823248Phase 1/2Unknown
Jianpi Huoxue Recipe in Treating Gastric Premalignant Lesion
Role: collaborator
NCT04408261Phase 2Unknown
BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome
Role: collaborator
NCT03580239Phase 3Unknown
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
Role: collaborator
All 3 trials loaded